أفضل طبيب أورام في نيودلهي سرطان الثدي, سرطان الصدر, سرطان الجهاز الهضمي, سرطان الجهاز البولي, سرطان الدم

• Dr. Mohit Agarwal is a dynamic medical oncologist with nearly a decade of clinical experience. After completing his MBBS from prestigious MAMC and MD (Medicine) from LHMC, his firm belief that CANCER CARE IS POSSIBLE, led him to pursuit Medical Oncology from Rajiv Gandhi Cancer Institute. Finding unawareness and myths as the biggest barrier to cancer treatment, he has started a 'Stop Cancer' initiative which involves lectures, CME's at National, International level and patient assistance programs. He has vast experience of treating solid & hematological malignancies. His keen area of interest are Breast, Lung, Gastro-intestinal, genitourinary, hepatobiliary carcinoma and lymphoma. His expertise includes all type of chemotherapy including targeted therapies, immunotherapies, hormone therapy, intraperitoneal therapy, intrathecal therapy and intensive protocols. He has been accredited with European certification (ECMO) by European Society of Medical Oncologist and has also awarded by CD foundation for outstanding contribution in field of cancer. He is actively involved in Clinical Research in cancer and has also done professional Diploma in Clinical Research. He is a teacher / faculty involved in teaching of medical students pursuing medical oncology and a thesis guide for the same. He has been a speaker, panelist, chairperson at various national and international cancer conferences. He also has multiple research papers in National and International journals

معلومات

• مستشفى فورتيس ، شاليمار باغ ، نيودلهي ، نيودلهي
• AA-299 ، شهيد أودهام سينغ مارج ، كتلة AA ، بوربي شاليمار باج ، شاليمار باغ ، دلهي ، 110088

التعليم

• MBBS from MAMC
• MD (Medicine) from LHMC

الجوائز والتقدير

• Accreditation of ESMO Europe Certified Medical Oncology Facilitated for outstanding contribution in cancer case by CD foundation

الخبرة

• Additional Director at Fortis Hospital, Shalimar Bagh

مجالات الاهتمام

• Breast, Lung, Gastro-intestinal, genitourinary, hepatobiliary carcinoma and lymphoma